Breaking News Instant updates and real-time market news.

LITE

Lumentum

$44.50

0.26 (0.59%)

, FNSR

Finisar

$30.64

-0.02 (-0.07%)

05:33
10/11/16
10/11
05:33
10/11/16
05:33

Lumentum downgraded to Sell from Neutral at Goldman

Goldman Sachs analyst Doug Clark downgraded Lumentum (LITE) to Sell saying product substitution and competition are risks to the company's "premium" valuation. Lumentum is slightly behind competitors in terms of timing of new product ramp, Clark tells investors in a research note. His $36 price target represents 19% downside. The analyst this morning also upgraded Finisar (FNSR) to Buy and kept Neutral ratings on Acacia Communications (ACIA) and Infinera (INFN) in a research note on the Optical Components space.

LITE

Lumentum

$44.50

0.26 (0.59%)

FNSR

Finisar

$30.64

-0.02 (-0.07%)

ACIA

Acacia Communications

$92.50

-7.5 (-7.50%)

INFN

Infinera

$9.44

0.02 (0.21%)

  • 26

    Oct

  • 14

    Nov

LITE Lumentum
$44.50

0.26 (0.59%)

08/11/16
MSCO
08/11/16
DOWNGRADE
MSCO
Underweight
Lumentum downgraded to Underweight from Equal Weight at Morgan Stanley
08/16/16
NEED
08/16/16
NO CHANGE
Target $54
NEED
Buy
Fabrinet price target raised to $54 from $48 at Needham
Needham analyst Alex Henderson raised his price target for Fabrinet (FN) to $54 from $48 following the company's better than expected quarterly results and "sharp raise" to guidance. The analyst expects further beat and raise quarters with visibility well out into the first half of 2017. Moreover, Henderson believes the news flow reads through to NeoPhotonics (NPTN), Oclaro (OCLR), and Lumentum (LITE). He reiterates a Buy rating on Fabrinet's shares.
08/18/16
NEED
08/18/16
NO CHANGE
NEED
Nokia, Alcatel-Lucent win positive for optical component companies, says Needham
Needham analyst Alex Henderson says that Alcatel-Lucent (ALU)/Nokia (NOK) announcement of a major contract win to build over 30% share of China Mobile's (CHL) 2016-2017 new construction of optical network is also a major positive for optical component companies such as Oclaro (OCLR), NeoPhotonics (NPTN), Fabrinet (FN), Lumentum (LITE), Inphi (IPHI), and Acacia (ACIA). Henderson thinks this is likely the first of three major awards in China, which will likely result in the current sold-out conditions in the coherent optical market to stretch out well into 2017.
10/05/16
PIPR
10/05/16
NO CHANGE
Target $27
PIPR
Overweight
Piper recommends exposure to optical component names
Piper Jaffray analyst Troy Jensen raised his estimates for all companies in his optical component coverage saying strength in optical demand will continue. Consensus estimates don't reflect the magnitude and sustainability of 100G cycle, Jensen tells investors in a research note. He recommends investors get exposure to the group. The analyst raised his price target for Applied Optoelectronics (AAOI) to $27 from $24, for Fabrinet (FN) to $53 from $50, for Finisar (FNSR) to $38 from $31, for Lumentum (LITE) to $47 from $38, for NeoPhotonics (NPTN) to $20 from $17 and for Oclaro (OCLR) to $10.50 from $9. Jensen has Overweight ratings on all six names.
FNSR Finisar
$30.64

-0.02 (-0.07%)

09/09/16
09/09/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Chesapeake (CHK) upgraded to Buy from Hold at Wunderlich with analyst Jason Wangler saying the company's assets are performing and its balance sheet is improving. 2. GameStop (GME) upgraded to Buy from Neutral at Hilliard Lyons. 3. Finisar (FNSR) upgraded to Buy from Neutral at MKM Partners with analyst Michael Genovese saying he is "extremely upbeat on the Optical components/module industry," and Chinese demand for 10G and 100G Optical modules appears it can stay strong for multiple years. 4. Randgold (GOLD) upgraded to Buy from Neutral at UBS with the firm citing the recent pullback in the shares and the potential for a dividend raise in 2017. 5. Teekay LNG (TGP) upgraded to Outperform from Market Perform at Wells Fargo analyst Michael Webber saying the discount to net asset value and the company's progress around financing its order book make the valuation "particularly compelling." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/09/16
STFL
09/09/16
NO CHANGE
STFL
Finisar price target raised to $33 from $28 at Stifel
Stifel analyst Patrick Newton raised his price target on Finisar after the company reported stronger than expected results. The analyst says that "improved mix" and the company's decision to eliminate its low margin wireless business enabled it to increase its gross margin guidance to 34%, well above his 32% estimate. Newton says that his positive thesis on the company is playing out more quickly than expected, and he keeps a Buy rating on the shares.
10/11/16
GSCO
10/11/16
UPGRADE
Target $39
GSCO
Buy
Finisar upgraded to Buy from Neutral at Goldman
Goldman Sachs analyst Doug Clark upgraded Finisar to Buy saying the company's key product cycles in the Telecom market should drive further revenue growth acceleration. Clark sees the potential for "substantial potential margin upside" and upped his price target for the shares to $39 from $24.
ACIA Acacia Communications
$92.50

-7.5 (-7.50%)

09/09/16
DBAB
09/09/16
NO CHANGE
Target $125
DBAB
Buy
Acacia Communications price target raised to $125 from $90 at Deutsche Bank
Deutsche Bank analyst Vijay Bhagavath raised his price target for Acacia Communications to $125 from $90 after joining the company's CEO and CFO in a non-deal roadshow. The analyst sees "little risk" to Q3 estimates given solid near-term order visibility in Datacenter Optical and China Metro build outs. The consensus view of Acacia's total addressable market at $4B is conservative and does not factor in up-sell into a $1B-$2B 100G Switching and Routing market, Bhagavath tells investors in a research note. He reiterates a Buy rating on the shares. Acacia closed yesterday down $2.31 to $117.89.
09/01/16
BOFA
09/01/16
NO CHANGE
Target $130
BOFA
Buy
Acacia Communications price target raised ot $130 from $88 at BofA/Merrill
BofA/Merrill analyst Tal Llani raised Acacia Communications' price target to $130 from $88 to reflect potential share gains and TAM expansion. The analyst remains constructive on shares despite recent strength given product superiority, sales growth, and potential upside to Street estimates. Llani rates Acacia a Buy.
09/06/16
NEED
09/06/16
NO CHANGE
Target $20
NEED
Strong Buy
Needham remains a buyer of NeoPhotonics ahead of analyst day
Needham analyst Alex Henderson believes NeoPhotonics (NPTN) is "exceptionally well positioned" for strong results over the next 3-4 quarters. The analyst "aggressively recommends" investors Buy NeoPhotonics' shares before the company's analyst day on September 8. Further, Henderson thinks Acacia's (ACIA) over $4B market cap will likely drive them to be acquisitive, and notes that it may seek to reduce costs as a percent of revenues by a potential acquisition of, for example, NeoPhotonics or Oclaro (OCLR). He reiterates a Strong Buy rating and $20 price target on NeoPhotonics' shares.
INFN Infinera
$9.44

0.02 (0.21%)

08/25/16
SBSH
08/25/16
DOWNGRADE
SBSH
Sell
Infinera downgraded to Sell with earnings seen pressued at Citi
As reported previously, Citi analyst Stanley Kovler downgraded Infinera to Sell from Neutral, as he expects additional margin pressure from R&D spending and its "aggressive" pursuit of Metro deals translating into "yet another leg down" in the company's earnings. With limited visibility until the second half of next fiscal year, Kovler cut his price target on Infinera shares to $8 from $10.
08/25/16
SBSH
08/25/16
NO CHANGE
Target $23
SBSH
Neutral
Ciena Q3 results should be relatively in-line, says Citi
Citi analyst Stanley Kovler raised his price target on Ciena (CIEN) to $23 from $21, saying that he expects a relatively in-line Q3 report from the company. He also removed the firm's High Risk rating on Ciena due to lower share volatility, but keeps a Neutral rating on the shares, saying that Infinera's (INFN) aggressive pricing in Ciena's metro markets outside of Tier 1, along with existing pricing pressure from other players, is a major risk going forward.
08/25/16
08/25/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Northrop Grumman (NOC) downgraded to Neutral from Overweight at JPMorgan with analyst Seth Seifman saying he recommends taking profits on shares and said cash flow estimates are below consensus due to capex projections. 2. Sprint (S) downgraded to Underperform from Neutral at Buckingham with analyst James Ratcliffe saying shares are more than pricing in continued improvement in subscriber and ARPU performance, along with capex at or below industry norms at current levels. 3. DHT Holdings (DHT) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Fotis Giannakoulis saying he expects crude tanker demand to lag fleet supply in 2017-2018 and sees potential pressure on the dividend. 4. Workday (WDAY) downgraded to Equal-Weight from Overweight at First Analysis with analyst Corey Greendale saying the company's second quarter results beat expectations but lowered its rating due to valuation. 5. Infinera (INFN) downgraded to Sell from Neutral at Citi with analyst Stanley Kovler saying he expects additional margin pressure from Research and Development spending and its "aggressive" pursuit of Metro deals translating into "yet another leg down" in the company's earnings. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/30/16
STFL
09/30/16
INITIATION
STFL
Hold
Infinera coverage resumed with a Hold at Stifel
Analyst PAtrick Newton resumed coverage of Infinera with a Hold rating and $9 price target. He says that the company's fate is tied to its 4th generation photonic integrated circuit (PIC) + FlexCoherent processor, dubbed the Infinite Capacity Engine, which will ramp throughout 2017. Consequently, he believes that the company faces elevated execution risk.

TODAY'S FREE FLY STORIES

OXY

Occidental Petroleum

$75.55

0.16 (0.21%)

, HES

Hess Corp.

$52.61

-1.23 (-2.28%)

07:14
01/22/18
01/22
07:14
01/22/18
07:14
Upgrade
Occidental Petroleum, Hess Corp. rating change  »

Occidental Petroleum…

OXY

Occidental Petroleum

$75.55

0.16 (0.21%)

HES

Hess Corp.

$52.61

-1.23 (-2.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Feb

  • 14

    Feb

07:13
01/22/18
01/22
07:13
01/22/18
07:13
General news
Futures lower as government shutdown enters day three »

Stock futures are…

AIG

AIG

$61.55

0.02 (0.03%)

07:12
01/22/18
01/22
07:12
01/22/18
07:12
Hot Stocks
Breaking Hot Stocks news story on AIG 

AIG trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Feb

  • 20

    Feb

  • 21

    Feb

VR

Validus

$46.72

0.81 (1.76%)

07:12
01/22/18
01/22
07:12
01/22/18
07:12
Hot Stocks
Breaking Hot Stocks news story on Validus 

Validus trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Feb

REXR

Rexford Industrial

$28.79

0.47 (1.66%)

07:11
01/22/18
01/22
07:11
01/22/18
07:11
Hot Stocks
Rexford Industrial acquires industrial property for $11.4M, sells one for $11.4M »

Rexford Industrial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALK

Alaska Air

$68.88

-0.91 (-1.30%)

, BA

Boeing

$337.73

-2.43 (-0.71%)

07:11
01/22/18
01/22
07:11
01/22/18
07:11
Hot Stocks
Alaska Air names Ray Conner to board »

Alaska Air Group (ALK),…

ALK

Alaska Air

$68.88

-0.91 (-1.30%)

BA

Boeing

$337.73

-2.43 (-0.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 31

    Jan

  • 21

    Feb

PCG

PG&E

$44.39

-0.11 (-0.25%)

07:10
01/22/18
01/22
07:10
01/22/18
07:10
Recommendations
PG&E analyst commentary  »

PG&E price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Feb

ENB

Enbridge

$39.39

-0.33 (-0.83%)

, SEP

Spectra Energy Partners

07:10
01/22/18
01/22
07:10
01/22/18
07:10
Hot Stocks
Enbridge, Spectra Energy Partners complete elimination of IDRs »

Enbridge (ENB) and…

ENB

Enbridge

$39.39

-0.33 (-0.83%)

SEP

Spectra Energy Partners

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

OMER

Omeros

$16.70

-0.02 (-0.12%)

07:10
01/22/18
01/22
07:10
01/22/18
07:10
Hot Stocks
Omeros receives positive opinion for OMS721 from EMA »

Omeros Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EIX

Edison International

$62.12

0.2 (0.32%)

07:10
01/22/18
01/22
07:10
01/22/18
07:10
Recommendations
Edison International analyst commentary  »

Edison International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWOU

2U

$72.38

1.49 (2.10%)

07:09
01/22/18
01/22
07:09
01/22/18
07:09
Hot Stocks
2U and WeWork partner in online graduate program expansion »

2U and WeWork Companies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NQ

NQ Mobile

$3.82

-0.07 (-1.80%)

07:07
01/22/18
01/22
07:07
01/22/18
07:07
Hot Stocks
NQ Mobile proposes to rebrand, change name to "Link Motion Inc." »

NQ Mobile announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLUE

bluebird bio

$175.95

-6.15 (-3.38%)

07:07
01/22/18
01/22
07:07
01/22/18
07:07
Technical Analysis
Technical Take: bluebird bio moves higher »

The stock was last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

OPB

Opus Bank

$28.70

0.05 (0.17%)

07:07
01/22/18
01/22
07:07
01/22/18
07:07
Earnings
Opus Bank reports Q4 EPS including items 3c, consensus 38c »

Reports net income of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

CQH

Cheniere Energy Partners LP

$28.22

0.22 (0.79%)

, CQP

Cheniere Energy Partners

$30.48

0.2 (0.66%)

07:06
01/22/18
01/22
07:06
01/22/18
07:06
Conference/Events
Morgan Stanley to hold a tour »

Annual Morgan Stanley…

CQH

Cheniere Energy Partners LP

$28.22

0.22 (0.79%)

CQP

Cheniere Energy Partners

$30.48

0.2 (0.66%)

ENLC

EnLink Midstream

$18.75

0.25 (1.35%)

ENLK

EnLink Midstream Partners

$17.45

0.37 (2.17%)

EPD

Enterprise Products

$28.66

0.36 (1.27%)

NBLX

Noble Midstream

$55.10

-0.48 (-0.86%)

PAA

Plains All American

$22.49

-0.09 (-0.40%)

SHLX

Shell Midstream

$30.13

-0.03 (-0.10%)

TRGP

Targa Resources

$50.73

0.04 (0.08%)

WES

Western Gas Partners

$52.31

0.34 (0.65%)

WGP

Western Gas Equity

$40.42

0.5 (1.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 22

    Jan

  • 23

    Jan

  • 07

    Feb

  • 16

    Feb

  • 20

    Feb

REGN

Regeneron

$371.53

0.25 (0.07%)

, SNY

Sanofi

$44.60

0.09 (0.20%)

07:06
01/22/18
01/22
07:06
01/22/18
07:06
Hot Stocks
Regeneron reports approval of Dupixent in Japan for atopic dermatitis »

Regeneron (REGN)…

REGN

Regeneron

$371.53

0.25 (0.07%)

SNY

Sanofi

$44.60

0.09 (0.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Feb

  • 08

    Mar

  • 25

    Mar

  • 02

    May

SLB

Schlumberger

$76.42

0.05 (0.07%)

07:06
01/22/18
01/22
07:06
01/22/18
07:06
Recommendations
Schlumberger analyst commentary  »

Schlumberger price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TTNP

Titan Pharmaceuticals

$1.28

0.025 (2.00%)

, BBRX

Braeburn Pharmaceuticals

07:06
01/22/18
01/22
07:06
01/22/18
07:06
Hot Stocks
Titan Pharmaceuticals discussing U.S. Probuphine commercialization with Braeburn »

Titan Pharmaceuticals…

TTNP

Titan Pharmaceuticals

$1.28

0.025 (2.00%)

BBRX

Braeburn Pharmaceuticals

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CC

Chemours

$54.02

2.42 (4.69%)

, MMM

3M

$248.18

2.27 (0.92%)

07:05
01/22/18
01/22
07:05
01/22/18
07:05
Conference/Events
ASHRAE and AHRI to co-host an expo »

The American Society of…

CC

Chemours

$54.02

2.42 (4.69%)

MMM

3M

$248.18

2.27 (0.92%)

ABB

ABB

$28.01

0.03 (0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 25

    Jan

  • 15

    Feb

07:05
01/22/18
01/22
07:05
01/22/18
07:05
General news
Oil Action: WTI benchmark futures are fractionally lower »

Oil Action: WTI benchmark…

ACBFF

Aurora Cannabis

$10.77

0.302 (2.89%)

07:05
01/22/18
01/22
07:05
01/22/18
07:05
Hot Stocks
CanniMed announces continuation of discussions with Aurora Cannabis »

CanniMed Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATNX

Athenex

$17.33

0.12 (0.70%)

07:04
01/22/18
01/22
07:04
01/22/18
07:04
Hot Stocks
Athenex announces results of first cohort of Phase 1b clinical trial of Oraxol »

Athenex announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LEVB

Level Brands

$5.10

-0.0385 (-0.75%)

07:03
01/22/18
01/22
07:03
01/22/18
07:03
Hot Stocks
Level Brands, Kathy Ireland announce extension of Isodiol license agreement »

Kathy Ireland, Chairman…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABAX

Abaxis

$61.16

0.35 (0.58%)

07:03
01/22/18
01/22
07:03
01/22/18
07:03
Hot Stocks
Abaxis granted USDA Approval for new VetScan FLEX4 Rapid Test »

Abaxis' new VetScan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

QURE

uniQure

$17.99

-0.01 (-0.06%)

07:03
01/22/18
01/22
07:03
01/22/18
07:03
Hot Stocks
uniQure receives OMPD in EU for AMT-130 »

uniQure announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.